Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma

Sanjal Desai, MD, Stephen Fernandez, Anusha Vakiti, MD, Facundo Stingo, MD, Tripti Adhikari, MD, Emily Paku, Aarthi Shenoy, MD, Vera Malkovska, MD, Dawn Fishbein, MD

Blood (2019) 134 (Supplement_1): 1614.

https://doi.org/10.1182/blood-2019-127520

Published: 2019

Journal Articles

Reversion of anergy signatures in clonal CD21 low B cells of mixed cryoglobulinemia after clearance of HCV viremia

Martina Del Padre, Laura Todi, Milica Mitrevski, Ramona Marrapodi, Stefania Colantuono, Massimo Fiorilli, Milvia Casato, Marcella Visentini

Blood (2017) 130 (1): 35–38.

https://doi.org/10.1182/blood-2017-03-771238

Published: 2017

Includes: Supplemental data

Journal Articles

How I treat cryoglobulinemia

Eli Muchtar, Hila Magen, Morie A. Gertz

Blood (2017) 129 (3): 289–298.

https://doi.org/10.1182/blood-2016-09-719773

Published: 2017

Journal Articles

Auto-Immune Origin of B Cells from HCV-Associated Lymphoma

Marine Armand, Myriam Boudjoghra, Aliki Xochelli, Danielle Canioni, Magali Le Garff Tavernier, Monica Colombo, Pascaline Rabiega, Thierry Molina, Frederic Charlotte, Jean-Marie Michot, Claude Lesty, Fabrice Carrat, Manlio Ferrarini, Kostas Stamatopoulos, Caroline Besson, Olivier Hermine, Frederic Davi

Blood (2015) 126 (23): 1464.

https://doi.org/10.1182/blood.V126.23.1464.1464

Published: 2015

Journal Articles

Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF)

Gaetane Nocturne, MD, Saida Boudaoud, Caroline Besson, MD PhD, Frederic Davi, MD PhD, Danielle Canioni, MD, Patrice Cacoub, Olivier Hermine, MD PhD, Xavier Mariette, MD PhD

Blood (2014) 124 (21): 1641.

https://doi.org/10.1182/blood.V124.21.1641.1641

Published: 2014

Journal Articles

Hematological Complications in chronic Hepatitis C Virus Infection

Magdalena Wrotkowska, MS, Piotr Stalke, MD PhD, Tomasz Smiatacz, MD PhD, Jan Maciej Zaucha, MD PhD

Blood (2014) 124 (21): 2169.

https://doi.org/10.1182/blood.V124.21.2169.2169

Published: 2014

Journal Articles

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

Blood (2012) 119 (25): 5996–6004.

https://doi.org/10.1182/blood-2011-12-396028

Published: 2012

Includes: Supplemental data

Journal Articles

The V H 1-69–expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21 low phenotype

Marcella Visentini, Maria Cagliuso, Valentina Conti, Maurizio Carbonari, Milvia Casato, Massimo Fiorilli

Blood (2011) 118 (12): 3440–3441.

https://doi.org/10.1182/blood-2011-05-353821

Published: 2011

Journal Articles

Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21 low B-cell subset

Edgar D. Charles, Claudia Brunetti, Svetlana Marukian, Kimberly D. Ritola, Andrew H. Talal, Kristen Marks, Ira M. Jacobson, Charles M. Rice, Lynn B. Dustin

Blood (2011) 117 (20): 5425–5437.

https://doi.org/10.1182/blood-2010-10-312942

Published: 2011

Includes: Supplemental data

Journal Articles

Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed cryoglobulinemia: a long-term study

Franco Dammacco, Felicia Anna Tucci, Gianfranco Lauletta, Pietro Gatti, Valli De Re, Vincenza Conteduca, Silvia Sansonno, Sabino Russi, Maria Addolorata Mariggiò, Maria Chironna, Domenico Sansonno

Blood (2010) 116 (3): 343–353.

https://doi.org/10.1182/blood-2009-10-245878

Published: 2010

Journal Articles

Peg-interferon α/ribavirin with and without rituximab for hepatitis C–related mixed cryoglobulinemia

Blood (2010) 116 (3): 504–505.

https://doi.org/10.1182/blood-2010-06-293787

Published: 2010

Journal Articles

Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia

David Saadoun, Mathieu Resche Rigon, Damien Sene, Benjamin Terrier, Alexandre Karras, Laurent Perard, Yoland Schoindre, Brigitte Coppéré, François Blanc, Lucile Musset, Jean-Charles Piette, Michele Rosenzwajg, Patrice Cacoub

Blood (2010) 116 (3): 326–334.

https://doi.org/10.1182/blood-2009-10-248518

Published: 2010

Journal Articles

Safety and efficacy of rituximab in patients with hepatitis C virus–related mixed cryoglobulinemia and severe liver disease

Antonio Petrarca, Luigi Rigacci, Patrizio Caini, Stefano Colagrande, Paolo Romagnoli, Francesco Vizzutti, Umberto Arena, Carlo Giannini, Monica Monti, Paolo Montalto, Marco Matucci-Cerinic, Alberto Bosi, Giacomo Laffi, Anna Linda Zignego

Blood (2010) 116 (3): 335–342.

https://doi.org/10.1182/blood-2009-11-253948

Published: 2010

Journal Articles

Chronic Lymphocytic Leukemia with Stereotyped IGHV4-59/IGKV3-20 B Cell Receptors: Another Manifestation of Hepatitis C Virus-Associated B Cell Lymphoproliferation?.

Efterpi Kostareli, Agnieszka Janus, Maria Gounari, Chrysoula Belessi, Sarka Pospisilova, David Oscier, Letizia Foroni, Paola Francia di Celle, Jesper Jurlander, Richard Rosenquist, Frederic Davi, Keith Thompson, Paolo Ghia, Kostas Stamatopoulos

Blood (2009) 114 (22): 2331.

https://doi.org/10.1182/blood.V114.22.2331.2331

Published: 2009

Journal Articles

Characterization of Antibodies Direct against the Idiotypic VK3 Chain of HCV-Related Type-II Mixed Cryoglobulinemia and B-Cell Proliferations

Valli De Re, PhD, Maria Paola Simula, Alessandro Pavan, Dolores Marin, Laura Caggiari, Giuseppe Toffoli

Blood (2008) 112 (11): 4988.

https://doi.org/10.1182/blood.V112.11.4988.4988

Published: 2008

Journal Articles

Characterization of Circulating Monoclonal B Lymphocytes in Patients with HCV Infection

Korenori Ohtsubo, Takashi Okamura, Michio Sata, Takumi Kawaguchi, Satoshi Morishige, Yuka Takata, Eijiro Oku, Rie Imamura, Ritsuko Seki, Michitoshi Hashiguchi, Koichi Osaki, Kazuaki Yakushiji, Taisuke Kanaji, Kohji Yoshimoto, Takato Ueno

Blood (2008) 112 (11): 4911.

https://doi.org/10.1182/blood.V112.11.4911.4911

Published: 2008

Journal Articles

Clonal CD27+ CD19+ B-Cell Expansion through Inhibition of FCgIIR in HCV+ Lymphorpoliferative Disorders

Valli De Re, PhD, Alessandro Pavan, Vito Racanelli, Silvia Sansonno, Giuseppe Toffoli

Blood (2008) 112 (11): 4923.

https://doi.org/10.1182/blood.V112.11.4923.4923

Published: 2008

Journal Articles

Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?

Carlo Giannini, Laura Gragnani, Alessia Piluso, Patrizio Caini, Antonio Petrarca, Monica Monti, Giacomo Laffi, Anna Linda Zignego

Blood (2008) 112 (10): 4353–4354.

https://doi.org/10.1182/blood-2008-07-170613

Published: 2008

Journal Articles

Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development

Valli De Re, Salvatore De Vita, Domenico Sansonno, Giuseppe Toffoli

Blood (2008) 111 (12): 5760.

https://doi.org/10.1182/blood-2008-04-149567

Published: 2008

Journal Articles

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis

David Saadoun, Michelle Rosenzwajg, Dan Landau, Jean Charles Piette, David Klatzmann, Patrice Cacoub

Blood (2008) 111 (11): 5334–5341.

https://doi.org/10.1182/blood-2007-11-122713

Published: 2008

NARROW

Virologic Clearance of Hepatitis C Is Associated with Improved Outcomes in African American Patients with Lymphoma

Reversion of anergy signatures in clonal CD21 low B cells of mixed cryoglobulinemia after clearance of HCV viremia

How I treat cryoglobulinemia

Auto-Immune Origin of B Cells from HCV-Associated Lymphoma

Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF)

Hematological Complications in chronic Hepatitis C Virus Infection

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

The V H 1-69–expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21 low phenotype

Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21 low B-cell subset

Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed cryoglobulinemia: a long-term study

Peg-interferon α/ribavirin with and without rituximab for hepatitis C–related mixed cryoglobulinemia

Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia

Safety and efficacy of rituximab in patients with hepatitis C virus–related mixed cryoglobulinemia and severe liver disease

Chronic Lymphocytic Leukemia with Stereotyped IGHV4-59/IGKV3-20 B Cell Receptors: Another Manifestation of Hepatitis C Virus-Associated B Cell Lymphoproliferation?.

Characterization of Antibodies Direct against the Idiotypic VK3 Chain of HCV-Related Type-II Mixed Cryoglobulinemia and B-Cell Proliferations

Characterization of Circulating Monoclonal B Lymphocytes in Patients with HCV Infection

Clonal CD27+ CD19+ B-Cell Expansion through Inhibition of FCgIIR in HCV+ Lymphorpoliferative Disorders

Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?

Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development

Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only